Cambridge, United Kingdom

Thierry Bonnaud

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 40(Granted Patents)


Location History:

  • Essex, GB (2011)
  • Cambridge, MA (US) (2021)
  • Cambridge, GB (2013 - 2023)

Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Thierry Bonnaud's Contributions to Pharmaceutical Innovations

Introduction:

Thierry Bonnaud, a distinguished inventor based in Cambridge, GB, has made significant contributions to the field of pharmaceutical innovations. With a notable track record of 14 patents to his name, Bonnaud continues to push the boundaries of scientific discovery in the realm of antibiotic-resistant bacterial infections.

Latest Patents:

One of Bonnaud's recent patents involves Tebipenem pivoxil crystalline forms, compositions, and methods of use. This groundbreaking patent introduces new crystalline salt forms of tebipenem pivoxil, offering innovative solutions for treating antibiotic-resistant bacterial infections. The patent encompasses various salt forms, including ethane sulfonate, ketoglutarate, maleate, malate, methane sulfonate, hydrobromide, and edisylate, each designed to enhance efficacy in combatting bacterial infections.

Career Highlights:

Throughout his career, Bonnaud has demonstrated a strong commitment to advancing pharmaceutical research. He has been associated with esteemed companies such as Neurocrine Biosciences, Inc. and Mycovia Pharmaceuticals, Inc., where he has played a pivotal role in developing cutting-edge medications to address critical medical needs. Bonnaud's expertise in pharmacology and drug development has solidified his standing as a leading figure in the pharmaceutical industry.

Collaborations:

Collaboration plays a key role in Bonnaud's innovative endeavors. Working closely with accomplished colleagues like Andrew Carr and Kevin McGee, Bonnaud has fostered a collaborative environment conducive to groundbreaking discoveries. By leveraging the diverse skill sets and perspectives of his coworkers, Bonnaud has been able to explore new avenues of research and drive impactful innovations in the pharmaceutical landscape.

Conclusion:

In conclusion, Thierry Bonnaud stands out as a visionary inventor with a passion for developing novel solutions to combat antibiotic-resistant bacterial infections. His extensive patent portfolio and successful industry collaborations underscore his invaluable contributions to the field of pharmaceutical innovations. Bonnaud's relentless pursuit of scientific excellence continues to inspire progress and innovation in the quest for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…